TITLE

CLINICAL EVALUATION OF RELAXIN IN ULCERATIVE ISCHEMIC VASCULAR OR COLLAGEN DISEASES

AUTHOR(S)
Bradham, Gilbert B.; Stallworth, J. Manly; Brailsford, Lucien E.; Threatt, Barbara A.
PUB. DATE
September 1962
SOURCE
Angiology;Sep1962, Vol. 13 Issue 9, p418
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
There were 26 patients treated with the drug relaxin in combination with small amounts of estrogen; 17 of them received sufficient relaxin to be considered in the final analysis. In this group there were no significant changes in oscillometric studies, skin temperature, plethysmography or peripheral uptake studies using radioiodinated serum albumin. Eleven patients showed, five exhibited essentially no clinical change and one experienced progression of the disease process. Possible causes for the improvement are discussed.
ACCESSION #
16370021

 

Related Articles

  • Sex Steroid Hormones and Cell Dynamics in the Periodontium. Mariotti, Angelo // Critical Reviews in Oral Biology & Medicine;1994, Vol. 5 Issue 1, p27 

    The biological changes that occur in tissues of the periodontium during puberty, the menstrual cycle, pregnancy, menopause, and oral contraceptive use have heightened interest in the relationship between sex steroid hormones and periodontal health. These clinical observations coupled with tissue...

  • Estrogen, A Double-Edged Sword: Modulation of TH1- and TH2-Mediated Inflammations by Differential Regulation of TH1 / TH2 Cytokine Production. Salem, Mohamed Labib // Current Drug Targets - Inflammation & Allergy;Mar2004, Vol. 3 Issue 1, p97 

    Estrogen appears to play a central role in the immune response and immunemediated diseases. Estrogen receptors are expressed in a variety of immunocompetent cells, including CD4+ and CD8+ T cells and macrophages. Clinical observations indicate that some autoimmune diseases, such as rheumatoid...

  • Preliminary Observations on Differing Psychological Effects of Conjugated and Esterified Estrogen Treatments. Friebely, Joan S.; Shifren, Jan L.; Schiff, Isaac; Regestein, Quentin R. // Journal of Women's Health & Gender-Based Medicine;Mar2001, Vol. 10 Issue 2, p181 

    During a double-blind comparison of menopausal replacement therapy with estrogen alone compared with estrogen plus methyltestosterone (meT), subjects who had been on conjugated equine estrogen (CEE) said they felt better when placed on esterified estrogen (EE). We, therefore, tested whether...

  • Sex hormones and oesophageal adenocarcinoma: influence of childbearing? Lagergren, J.; Jansson, C. // British Journal of Cancer;10/17/2005, Vol. 93 Issue 8, p859 

    The male predominance of oesophageal adenocarcinoma might be explained by oestrogen protection in women. If true, female patients might have sex hormonal disturbances rendering impaired fertility. The influence of childbearing on the risk of oesophageal adenocarcinoma was investigated in a...

  • Synthesis and Anti-implantation Activity of New Stilbene Derivatives. Bandichhor, Rakeshwar; Singh, Kunwar A.; Nosse, Bernd; Tandon, Vishnu K. // Drug Research / Arzneimittel-Forschung;Aug2004, Vol. 54 Issue 8, p452 

    New stilbene (CAS 56-53-1) derivatives have been synthesized by reductive elimination of desoxybenzoin analogs which were obtained by Fries rearrangement of the corresponding phenolic esters. The chemical structures of the compounds obtained were confirmed by �H-NMR, IR and elemental...

  • Estrogen Receptors as Therapeutic Targets in Breast Cancer. Ariazi, Eric A.; Ariazi, Jennifer L.; Cordera, Fernando; Jordan, V. C. // Current Topics in Medicinal Chemistry;Feb2006, Vol. 6 Issue 3, p195 

    The estrogen receptor a (ERa) has proven to be the single most important target in breast cancer over the last 30 years. The use of the selective ER modulator (SERM) tamoxifen for the treatment and prevention of breast cancer has changed therapeutics. The SERM raloxifene, approved for the...

  • Estrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders. Ariazi, Eric A.; Jordan, V. C. // Current Topics in Medicinal Chemistry;Feb2006, Vol. 6 Issue 3, p181 

    While estrogen receptor (ER)-targeted therapeutics have clearly been a success in the treatment of breast cancer, the orphan estrogen-related receptors (ERRs) represent novel targets for future development. The ERRs, comprising ERRa, ERR� and ERR?, bind and regulate transcription via...

  • Synthesis and Preliminary Biological Evaluation of Estrone Dimers. Rabouina, Daniel; Perrona, Val�rie; N'Zemba, Blaise; Guptaa, Atul; Gaudreault, Ren�-C.; B�rube, Gervais // Letters in Drug Design & Discovery;Apr2007, Vol. 4 Issue 3, p171 

    A rapid and efficient synthesis of estrogenic dimers, with 45% overall yield, is described. The new molecules possess two estrone units linked at position 16, with either an alkyl chain or a polyethylene glycol chain. The biological activity of these compounds was evaluated in vitro on estrogen...

  • Estrogen(s) and Analogs as a Non-Immunogenic Endogenous Ligand in Targeted Drug/DNA Delivery. Rai, Shivani; Paliwal, Rishi; Vaidya, Bhuvaneshwar; Gupta, Prem N.; Mahor, Sunil; Khatri, Kapil; Goyal, Amit K.; Rawat, Amit; Vyas, S. P. // Current Medicinal Chemistry;2007, Vol. 14 Issue 19, p2095 

    The maximum therapeutic potentials of pharmacologically active molecules are generally not attained due to their non specific delivery. Ligands associated with drug or delivery system through which it is delivered provide navigation and direction to the carrier system(s) so as to reach and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics